DermTech Stock (NASDAQ: DMTK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 295.092K |
Day Range | - - - |
52 Wk Range | 0.580 - 3.930 |
Market Cap | $21.484M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 9.44% |
Days to Cover | 14.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DermTech (NASDAQ: DMTK) through any online brokerage.
Other companies in DermTech’s space includes: Vincerx Pharma (NASDAQ:VINC), CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Galecto (NASDAQ:GLTO) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for DermTech (NASDAQ: DMTK) was reported by Lake Street on Friday, April 19, 2024. The analyst firm set a price target for 0.63 expecting DMTK to rise to within 12 months (a possible 1.53% upside). 6 analyst firms have reported ratings in the last year.
The stock price for DermTech (NASDAQ: DMTK) is $0.6205 last updated April 25, 2024 at 9:18 AM EDT.
There are no upcoming dividends for DermTech.
DermTech’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for DermTech.
DermTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.